CD4 and non-small cell lung carcinoma: Huang et al. [48] brought T lymphocytes subpopulations into studies and identified that CD3−CD16+CD56+ cells, CD3+CD4+ cells and Treg cells were significantly correlated with the prognostic of NSCLC patients.